Objective: To evaluate diffusion-weighted imaging for predicting theresponse after chemoembolization of hepatocellular carcinoma bycomparing the pretreatment ADC values.Materials and methods: The30patients were chosen who werediagnosed with hepatocellular carcinoma and never treated with TACE.Before TACE every patient was checked with MR DWI (b=400s/mm2,600s/mm2,800s/mm2); and the nodular type nodules were selected. Thedates were grouped into two groups according to the follow-up imagesresults: the responding group and nonresponding one. The mean ADCvalues were measured and the coefficient of variance (CV) was calculated.Then we compared the two groups.Results:36areas of30patients were chosen. The ADC values(10-3mm2/s) of the responding group and nonresponding group atdifferent b values (b=400s/mm2,600s/mm2,800s/mm2) were1.29±0.25ã€1.49±0.26,1.23±0.27ã€1.47±0.28,1.17±0.26ã€1.45±0.26; there werestatistic difference between the two groups at the same b value. The CVsof the responding group and nonresponding group at different b valueswere0.102±0.042ã€0.135±0.047,0.095±0.040ã€0.157±0.035,0.097±0.040ã€0.140±0.058; there were statistic difference between thetwo groups at the same b value. The areas of the ADC values ROC atdifferent b values were0.708ã€0.752ã€0.762separately, and the thresholds〠sensitivity and specificity were1.44×10-3mm2/sã€66.7%ã€81%,1.43×10-3mm2/sã€66.7%ã€85.7%,1.45×10-3mm2/sã€55.3%ã€95.2%;The areas of the CVs ROC at different b values were0.724ã€0.848ã€0.768separately, and the thresholds〠sensitivity and specificity were0.116ã€73.3%ã€85.7%,0.121ã€86.7%ã€90.5%,0.117ã€80%ã€85.7%.Conclusion: The mean ADC values and CVs of nodules ofhepatocellular carcinoma could predict the response after transarterialchemoembolization, and the lower ADC values and CVs, the better of theprognosis. When the b value was800s/mm2, the prediction of ADC valuewas better; and when the b value was600s/mm2, the prediction of CVswas better. |